If proven safe and effective, gene therapy targeting GJB2 mutations could offer the first disease-modifying treatment for one of the most common causes of inherited hearing loss, fundamentally reshaping the audiology care pathway.

✦ Earlier

Hearing Health Matters·Press release·Research (general)·3mo ago

Skylark Bio to Present New Preclinical Data for Pendrin Gene Therapy Targeting Hearing Loss Program at ASGCT 2026

Gene therapies targeting specific genetic causes of hearing loss represent a potential future treatment paradigm that could shift audiology from management to cure for select patient populations.

✦ Search

✦ Filter

2 dispatches

✦ Top desks

All →

PubMed1659
ASHA Voices308
The Hearing Journal Podcast200
Hearing Health Matters149
Hearing Review143
Hearing Tracker140
Doctor Cliff, AuD140
Hearing Practitioner Australia139
Hear Us Out119
Aurahear112
The Hearing Matters Podcast110
Tinnitus Relief w/ Dr. Ben Thompson105
Future Ear Radio100
Starkey Sound Bites87
empowEar Audiology78
Audiology Worldnews78

The Hearing Wirebroadsheet

An editorialised feed of audiology, hearing-health, and industry signals — gathered from the desks audiologists already trust.

✦ The Desks

Live dispatches
Story clusters
All sources
Research watch
Industry watch

✦ The Masthead

About this paper
Editorial policy
HearingTracker
Contact the editor

✦ Search

✦ Filter

2 dispatches